Upstream Bio (UPB) Property, Plant & Equipment (Net) (2023 - 2026)
Upstream Bio (UPB) Property, Plant & Equipment (Net) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | 642,333.36 |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | 5.32 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 1.64 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 1.61 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | 5.27 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 518.26 Mn |
| 10 | Upstream Bio | 346.10 Mn | 346.10 Mn | -3.94 Mn | 510,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 510,000.00 |
| Mar 31, 2026 | 510,000.00 |
| Dec 31, 2025 | 559,000.00 |
| Dec 31, 2025 | 559,000.00 |
| Sep 30, 2025 | 616,000.00 |
| Sep 30, 2025 | 616,000.00 |
| Jun 30, 2025 | 544,000.00 |
| Jun 30, 2025 | 544,000.00 |
| Mar 31, 2025 | 539,000.00 |
| Mar 31, 2025 | 539,000.00 |
| Dec 31, 2024 | 582,000.00 |
| Dec 31, 2024 | 582,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Dec 31, 2023 | 159,000.00 |
| Dec 31, 2023 | 159,000.00 |